What is behind Sore Throat
The capacity to clear a pathogen before it establishes. The most important caution here: defense is inflammation at the molecular level — a product that lowered inflammation and raised resistance simultaneously would be working against the mechanism. Evidence A — Human trial evidence.
Immune surveillance — the standing patrol that detects and clears pathogens and aberrant cells. Evidence A — Human trial evidence.
The master inflammatory switch — indispensable to defend against threat, corrosive when it never stands down. Evidence B — Preclinical.
The transcription factor that commands the body's own antioxidant and detoxification arsenal. Evidence A — Human trial evidence.
Evidence on these pathways
Immune Surveillance → Infection Resistance. “Primary Immunodeficiencies (PID) are genetically inherited disorders characterized by defects of the immune system, leading to increased susceptibility to infection.” — Diagnostics of Primary Immunodeficiency Diseases: A Sequencing Capture Approach. PLoS ONE, 2014, volume 9, e114901. doi:10.1371/journal.pone.0114901
Immune Surveillance → Muscle Recovery. “Macrophages are essential for the proper inflammatory and reparative processes that lead to regeneration of skeletal muscle after injury.” — Macrophage SREBP1 regulates skeletal muscle regeneration. Frontiers in Immunology, 2024 (volume 14), article 1251784. doi:10.3389/fimmu.2023.1251784
Immune Surveillance → Wound Healing. “Indeed, the depletion of macrophages is unmistakably detrimental to normal skin healing in adult mammals.” — Macrophages in Healing Wounds: Paradoxes and Paradigms. International Journal of Molecular Sciences, 2021, 22(2):950. doi:10.3390/ijms22020950
Infection Resistance → Fatigue. “A relatively uniform post-infective fatigue syndrome persists in a significant minority of patients for six months or more after clinical infection with several different viral and non-viral micro-organisms.” — Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ, 2006, volume 333, page 575. doi:10.1136/bmj.38933.585764.AE
Formulas that act on these pathways
Acts on 4 of these pathways: Infection Resistance, Immune Surveillance, NF-κB, Nrf2.
Acts on 4 of these pathways: Infection Resistance, Immune Surveillance, NF-κB, Nrf2.
Acts on 4 of these pathways: Infection Resistance, Immune Surveillance, NF-κB, Nrf2.
Acts on 4 of these pathways: Infection Resistance, Immune Surveillance, NF-κB, Nrf2.
Acts on 4 of these pathways: Infection Resistance, Immune Surveillance, NF-κB, Nrf2.
Acts on 3 of these pathways: Immune Surveillance, NF-κB, Nrf2.
What this page does not claim
This page names the pathways involved and the published evidence on each. It does not claim that any formula treats, cures or prevents Sore Throat. A pathway opens here only on graded, published evidence, under a standard fixed before the evidence was gathered, and every figure above carries its grade.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.